EGFR and glioblastoma: Molecular alterations considered to identify molecular GBM are Telomerase Reverse Transcriptase (TERT) promoter mutation, Epidermal Growth Factor Receptor (EGFR) gene amplification, and combined gain of chromosome 7 and loss of chromosome 10 [2,5].